Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

A Toll-like receptor recognizes bacterial DNA.

Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S.

Nature. 2000 Dec 7;408(6813):740-5. Erratum in: Nature 2001 Feb 1;409(6820):646.

PMID:
11130078
2.

TLR9 signals after translocating from the ER to CpG DNA in the lysosome.

Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, Knetter CF, Lien E, Nilsen NJ, Espevik T, Golenbock DT.

Nat Immunol. 2004 Feb;5(2):190-8.

PMID:
14716310
3.

Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments.

Ahmad-Nejad P, Häcker H, Rutz M, Bauer S, Vabulas RM, Wagner H.

Eur J Immunol. 2002 Jul;32(7):1958-68.

4.

Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62.

Goodridge HS, Marshall FA, Else KJ, Houston KM, Egan C, Al-Riyami L, Liew FY, Harnett W, Harnett MM.

J Immunol. 2005 Jan 1;174(1):284-93.

5.

Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88.

Schnare M, Holt AC, Takeda K, Akira S, Medzhitov R.

Curr Biol. 2000 Sep 21;10(18):1139-42.

6.

Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.

Vollmer J, Weeratna RD, Jurk M, Davis HL, Schetter C, Wüllner M, Wader T, Liu M, Kritzler A, Krieg AM.

J Leukoc Biol. 2004 Sep;76(3):585-93.

PMID:
15218053
7.

Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice.

Kaisho T, Akira S.

Trends Immunol. 2001 Feb;22(2):78-83. Review.

PMID:
11286707
8.

Endotoxin-induced maturation of MyD88-deficient dendritic cells.

Kaisho T, Takeuchi O, Kawai T, Hoshino K, Akira S.

J Immunol. 2001 May 1;166(9):5688-94.

9.

Toll-like receptor signaling in anti-cancer immunity.

Okamoto M, Sato M.

J Med Invest. 2003 Feb;50(1-2):9-24.

PMID:
12630564
10.

Toll-like receptors and their signaling mechanism in innate immunity.

Kaisho T, Akira S.

Acta Odontol Scand. 2001 Jun;59(3):124-30. Review.

PMID:
11501880
13.

Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.

Kandimalla ER, Bhagat L, Li Y, Yu D, Wang D, Cong YP, Song SS, Tang JX, Sullivan T, Agrawal S.

Proc Natl Acad Sci U S A. 2005 May 10;102(19):6925-30.

14.

TIRAP: an adapter molecule in the Toll signaling pathway.

Horng T, Barton GM, Medzhitov R.

Nat Immunol. 2001 Sep;2(9):835-41.

PMID:
11526399
15.

Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.

Uematsu S, Sato S, Yamamoto M, Hirotani T, Kato H, Takeshita F, Matsuda M, Coban C, Ishii KJ, Kawai T, Takeuchi O, Akira S.

J Exp Med. 2005 Mar 21;201(6):915-23.

16.

Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity.

Wagner H.

Curr Opin Microbiol. 2002 Feb;5(1):62-9. Review.

PMID:
11834371
17.

The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.

Horng T, Barton GM, Flavell RA, Medzhitov R.

Nature. 2002 Nov 21;420(6913):329-33.

PMID:
12447442
18.

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

Alexopoulou L, Holt AC, Medzhitov R, Flavell RA.

Nature. 2001 Oct 18;413(6857):732-8.

PMID:
11607032
19.

Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway.

Pichyangkul S, Yongvanitchit K, Kum-arb U, Hemmi H, Akira S, Krieg AM, Heppner DG, Stewart VA, Hasegawa H, Looareesuwan S, Shanks GD, Miller RS.

J Immunol. 2004 Apr 15;172(8):4926-33.

20.

Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation.

Hoshino K, Kaisho T, Iwabe T, Takeuchi O, Akira S.

Int Immunol. 2002 Oct;14(10):1225-31.

Items per page

Supplemental Content

Support Center